Cromwell Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$475K Sell
16,661
-1,954
-10% -$52K 0.21% 83
2026
Q2
$448K Buy
18,615
+143
+0.8% +$3.74K 0.2% 88
2026
Q1
$519K Hold
18,472
– – 0.29% 64
2025
Q4
$460K Buy
18,472
+3,740
+25% +$94.3K 0.25% 75
2025
Q3
$375K Hold
14,732
– – 0.2% 95
2025
Q2
$357K Sell
14,732
-3,801
-21% -$88.6K 0.22% 90
2025
Q1
$470K Buy
18,533
+7,250
+64% +$190K 0.3% 67
2024
Q4
$299K Buy
11,283
+3,645
+48% +$98.9K 0.17% 100
2024
Q3
$221K Buy
7,638
+7,591
+16,151% +$221K 0.14% 144
2024
Q2
$1.32K Buy
+47
New +$1.29K ﹤0.01% 609

Other funds holding PFE

Cromwell Holdings's PFE Position: Q3 2026 in Review

Cromwell Holdings reduced its Pfizer (PFE) stake by 10% in Q3 2026, selling an estimated $52K and leaving 16,661 shares worth $475K. The position accounts for 0.21% of the portfolio, ranked #83.

Cromwell Holdings first reported a position in PFE in Q2 2024 and has held it in 10 quarters since. The position peaked at $519K in Q1 2026. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Cromwell Holdings held 16,661 shares of Pfizer worth $475K as of Q3 2026.
  • Cromwell Holdings sold 1,954 Pfizer shares in Q3 2026, an estimated $52K.
  • Pfizer made up 0.21% of Cromwell Holdings's portfolio in Q3 2026, its #83 holding.
  • Cromwell Holdings first reported a position in Pfizer in Q2 2024 and has held it in 10 quarters since.
  • Cromwell Holdings's Pfizer position peaked at $519K in Q1 2026.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Cromwell Holdings's 13F filing for Q3 2026, filed 28 Oct 2026.